Amgen pleads guilty, to settle misbranding case for $762 million

Biotech giant Amgen Inc. pleaded guilty to a federal misdemeanor of misbranding its anemia drug Aranesp and has agreed to pay $762 million in fines and penalties.

3d human anatomy model free 3d human anatomy model